MTATP6P17

Across TCGA pan-cancer cohorts, MTATP6P17 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MTATP6P17’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where MTATP6P17 RNA is repressed in tumor relative to normal tissue. In most cancer types MTATP6P17 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

COAD are the cancer types where MTATP6P17 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTATP6P17 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	−0.027	.037	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

MTATP6P17–COAD

Open the COAD breakdown →